Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02189278 · ClinicalTrials.gov registry record · NA

Improving Adherence to Recommended Surveillance in Breast Cancer Survivors

A NA study of Breast Cancer, sponsored by Duke University.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02189278: Completed NA study of Breast Cancer, sponsored by Duke University.

NCT02189278 is a NA study of Breast Cancer that has completed, run by Duke University. The registered enrollment target is 100 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02189278, a NA study of Breast Cancer, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Evidence-based guidelines recommend cancer surveillance procedures for breast cancer survivors including physical examination, mammography, breast self-exam, and gynecologic follow-up. The early detection of recurrent and new cancers can best be achieved through the combined, on schedule use of these surveillance procedures. Yet, data suggest that up to 55% of breast cancer survivors do not undergo these procedures as recommended. This study tests a telephone-based psychosocial intervention aimed at improving adherence to recommended surveillance in breast cancer survivors. The psychosocial intervention for improving adherence is compared to treatment as usual.

Primary Outcome

Receipt of recommended mammograms and clinical breast exams (coded 0=no, 1=yes)

Conditions Studied

Interventions

  • BEHAVIORAL Psychosocial Intervention

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2013-10
Est. Completion 2017-06-12
Phase NA
Duke University

1,725 total trials

What the finished NCT02189278 record still lists

NCT02189278 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Psychosocial Intervention is the first listed.

NCT02189278 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02189278 about?

NCT02189278 is a clinical study titled "Improving Adherence to Recommended Surveillance in Breast Cancer Survivors". Evidence-based guidelines recommend cancer surveillance procedures for breast cancer survivors including physical examination, mammography, breast self-exam, and gynecologic follow-up. The early detection of recurrent and new cancers can best be achieved through the combined, on schedule use of thes...

What is the current status of trial NCT02189278?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2013-10. Estimated completion is 2017-06-12.

What conditions does trial NCT02189278 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02189278?

The interventions under investigation include: Psychosocial Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02189278?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02189278 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02189278's enrollment target sits among peer trials

100 565th of 1224 higher than 630 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02189278, the US trial registry maintained by the National Library of Medicine. NCT02189278 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.